Insights

Innovative Therapeutics Abzyme Therapeutics specializes in developing modular single domain VHH antibody fragments using proprietary discovery platforms, providing a unique approach that can appeal to clients seeking cutting-edge immunotherapy solutions.

Diverse Program Portfolio With over 60 proprietary and partnered programs across therapeutic and diagnostic areas such as infectious diseases, immuno-oncology, and CNS disorders, the company presents numerous opportunities for collaborations and licensing deals.

Recent Milestones The company’s achievement in reaching significant development milestones and securing a $1 million SBIR contract highlights its growth potential and potential readiness for strategic partnerships in advanced antibody therapies.

Niche Focus Areas Abzyme's focus on developing therapies for specialized fields like infectious diseases and neurodegenerative disorders offers targeted sales opportunities with biotech firms or research institutions prioritizing high-impact therapeutic areas.

Technology Edge Its proprietary in vitro antibody discovery platform enables rapid development of high-affinity, developable antibody fragments, giving it a competitive advantage when pitching partnerships or licensing opportunities to larger biopharma companies.

Abzyme Therapeutics Tech Stack

Abzyme Therapeutics uses 8 technology products and services including Cloudflare CDN, RSS, Microsoft 365, and more. Explore Abzyme Therapeutics's tech stack below.

Cloudflare CDN

Content Delivery Network

RSS

Content Management System

Microsoft 365

Font Awesome

Font Scripts

Lodash

Javascript Libraries

reCAPTCHA

Security

Genesis Framework

Web Platform Extensions

Gravity Forms

Web Platform Extensions

Abzyme Therapeutics Email Formats	Example	Percentage
First@abzymetx.com	John@abzymetx.com	42%
Last@abzymetx.com	Doe@abzymetx.com	33%
First.Last@abzymetx.com	John.Doe@abzymetx.com	17%
LastFirst@abzymetx.com	DoeJohn@abzymetx.com	8%

Abzyme Therapeutics Email Formats

Example

Percentage

First@abzymetx.com

John@abzymetx.com

42%

Last@abzymetx.com

Doe@abzymetx.com

33%

First.Last@abzymetx.com

John.Doe@abzymetx.com

17%

LastFirst@abzymetx.com

DoeJohn@abzymetx.com

Frequently Asked Questions

Where is Abzyme Therapeutics's headquarters located?

Abzyme Therapeutics's main headquarters is located at 321 Jones Boulevard Suite 300 Royersford, Pennsylvania 19468 United States. The company has employees across 2 continents, including North AmericaAsia.

What is Abzyme Therapeutics's phone number?

You can contact Abzyme Therapeutics's main corporate office by phone at

+1-610-990-****

. For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Abzyme Therapeutics's official website and social media links?

Abzyme Therapeutics's official website is abzymetx.com and has social profiles on LinkedIn.

What is Abzyme Therapeutics's SIC code NAICS code?

Abzyme Therapeutics's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Abzyme Therapeutics have currently?

As of March 2026, Abzyme Therapeutics has approximately 9 employees across 2 continents, including North AmericaAsia. Key team members include Chief Scientific Officer, Co-Founder: H. T.Director Of Business Development (consultant): S. M.Lab Manager / Research Scientist: A. P.. Explore Abzyme Therapeutics's employee directory with LeadIQ.

What industry does Abzyme Therapeutics belong to?

Abzyme Therapeutics operates in the Biotechnology Research industry.

What technology does Abzyme Therapeutics use?

Abzyme Therapeutics's tech stack includes Cloudflare CDNRSSMicrosoft 365Font AwesomeLodashreCAPTCHAGenesis FrameworkGravity Forms.

What is Abzyme Therapeutics's email format?

Abzyme Therapeutics's email format typically follows the pattern of First@abzymetx.com. Find more Abzyme Therapeutics email formats with LeadIQ.

When was Abzyme Therapeutics founded?

Abzyme Therapeutics was founded in 2010.

Abzyme Therapeutics

Q: What is Abzyme Therapeutics's official website and social media links?

Abzyme Therapeutics's official website is abzymetx.com. Abzyme Therapeutics has social profiles on LinkedIn.

Q: How many employees does Abzyme Therapeutics have currently?

Abzyme Therapeutics has approximately 9 employees.

Q: What technology does Abzyme Therapeutics use?

Abzyme Therapeutics's tech stack includes Priority Hints, PHP, WordPress, Google Maps, MySQL.

Q: What is Abzyme Therapeutics's NAICS code?

Abzyme Therapeutics's NAICS code is 541714 (Research and Development in Biotechnology (except Nanobiotechnology)).

Biotechnology ResearchPennsylvania, United States2-10 Employees

Abzyme Therapeutics is a biopharmaceutical company focused on developing modular single domain VHH antibody fragments for immunotherapy using proprietary antibody generation platforms. The company is located in the Eastern Pennsylvania biotechnology/pharmaceutical hub 30-miles west of Philadelphia.

Unique to Abzyme is our proprietary and highly engineered eukaryotic in vitro antibody discovery/optimization platform based on yeast display self-diversifying libraries, rapid target-directed antibody affinity maturation in combination with a FACS single cell sorting approach to identify desired antibodies. Abzyme’s modular antibody discovery platform incorporates a real-time screening ability to select for key properties such as epitopic diversity, binding affinity, expressibility, solubility, developability, broad-reactivity and target-specificity.

Today, the Company has over 60 proprietary and partnered programs in development in therapeutic and diagnostic areas including infectious diseases, immuno-oncology, ophthalmology, inflammation and central nervous system disorders.

Insights

Similar companies to Abzyme Therapeutics

Roche

sanofi

Johnson & Johnson

Merck

Pfizer

AstraZeneca

Novartis

Amgen